Not available for this issue.
A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.
Issue 003 | U.S. Pilot | US
PBM
PSYENCE BIOMEDICAL LTD.
Screen state: Needs Review
Source state: Stale Filing
20-F | 2025-07-25
Filing currency: USD
Internal NCAV Discount
71.9%
GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 6,560,274USD
- Total Liabilities
- 594,366USD
- NCAV
- 5,965,908USD
- Cash
- 6,135,166USD
- NCAV per share
- needs review
- Evidence
- 14 annual | 19 quarterly
Mary filing review
Financial Statement Evidence
Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.
- Evaluated
- 12
- Triggered
- 2
- Unavailable
- 6
Requires inspection Negative OCF -3,734,238
- Latest
- -3,734,2382025-03-31
- Comparison
- n/a
- Change
- n/a
Basis: latest reporting-period cash from operations < 0
Source periods: SEC 20-F 2025-03-31 · 0001213900-25-067748
Supporting observation Share Count Reduced 568,021
- Latest
- 568,0212025-03-31
- Comparison
- 13,390,6592024-03-31
- Change
- -95.8%
Basis: 1Y share change <= -2% using the same share-count source
Source periods: SEC 20-F 2025-03-31 · 0001213900-25-067748; REPORTED_FILING 20-F 2024-03-31
6 unavailable checks — inspect missing inputs
Current Ratio <= 1.5
current assets / current liabilities <= 1.5
Current Ratio > 1.5
current assets / current liabilities
High Debt
(short-term debt + long-term debt) / ordinary equity >= 50%
High NCAV Burn since the previous filing
NCAV burn since previous filing >= 10%; previous NCAV must be positive
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Non-Positive Equity
ordinary shareholders equity <= 0
Business Profile
Published only when a substantive filing-text profile has been prepared for this issue.
Known Unknowns
Only 19 quarterly periods available from Data Vault for this company.
Medium | Share Count
The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Medium | Filing
Some rows are based on older filing data and require manual freshness review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-03-31
20-F
USD
|
2024-03-31
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Income | 1,011,790 | -51,159,048 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cash From Operations | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | 6,135,166 | 733,188 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 7,316,370 | 1,132,159 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 594,366 | 12,104,699 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shareholders Equity | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding | 568,021 | 13,390,659 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Share Count Change (Normalized) | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence |
| Ownership Claim Change (Normalized) | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
Only 19 quarterly periods available from Data Vault for this company.
| Metric |
2025-09-30
6-K
USD
|
2025-03-31
6-K
USD
|
2024-09-30
6-K
USD
|
2024-03-31
6-K
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2024-01-25
20-F
USD
|
2023-09-30
6-K
USD
|
2023-03-31
6-K
USD
|
2022-03-31
6-K
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Income | -1,992,732 | 1,011,790 | 2,960,655 | -51,159,048 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1,606,414 | -3,206,403 | n/a |
| Cash From Operations | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | 7,149,985 | 6,135,166 | 1,932,519 | 733,188 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 605,480 | 1,334,280 | 1,753,437 |
| Total Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 943,068 | 594,366 | 3,508,604 | 12,104,699 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1,790,700 | 131,642 |
| Shares Outstanding | n/a | 568,021 | n/a | 13,390,659 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Share Count Change (Normalized) | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence |
| Ownership Claim Change (Normalized) | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | n/a | derived | 2025-09-30 | n/a | n/a |
| Total Liabilities | 943,068USD | ifrs-full:Liabilities | 2025-09-30 | 1.00 |
Data Vault | sec/companyfacts/cik=0001985062/companyfacts.json Data Vault | sec/companyfacts/cik=0001985062/companyfacts.json |
| Cash | 7,149,985USD | ifrs-full:CashAndCashEquivalents | 2025-09-30 | 1.00 |
Data Vault | sec/companyfacts/cik=0001985062/companyfacts.json Data Vault | sec/companyfacts/cik=0001985062/companyfacts.json |
| Shares Outstanding | n/a | n/a | 2025-09-30 | n/a | n/a |
| NCAV | n/a | derived | 2025-09-30 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | n/a | derived | 2025-09-30 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Internal NCAV Discount | 71.9% | derived | 2025-09-30 | n/a | gnni_publication_pack | internal_discount |
NCAV could not be calculated because one or more inputs are missing.
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- Local evidence | The Data Vault
- CIK
- 0001985062
- Company ID
- n/a
- Selected Annual Source
- Data Vault | sec/companyfacts/cik=0001985062/companyfacts.json
- Selected Quarterly Source
- Data Vault | sec/companyfacts/cik=0001985062/companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 4
- Imported At
- 2026-08-15T12:52:37+00:00
- Rendered At
- 2026-08-16T03:29:48+00:00
Run Audit
- Mary Run
- 8f67c1da7de642feb640d04491409c50
- Mary As Of
- 2026-07-25
- Accession
- 0001213900-25-067748
- CIK
- 0001985062
- Mary Filing Date
- 2025-07-25
- Filing Currency
- USD
- Internal Discount
- 71.9%
- Source State
- Stale Filing
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=8f67c1da7de642feb640d04491409c50; mary_as_of=2026-07-25; mary_filing_date=2025-07-25; mary_accession=0001213900-25-067748; mary_cik=0001985062; gnni_supporting_filing_date=2025-06-25; internal_discount=0.719127; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review